• Info
  • Insider Ownership

Insider Trading & Ownership of Jonathan McNeill

Location
Waltham, MA
Summary
The estimated net worth of Jonathan McNeill is at least $6.11M dollars as of 10 Dec 2025. Jonathan McNeill is the Chief Business Officer of Dyne Therapeutics, Inc. and owns shares of Dyne Therapeutics, Inc. (DYN) stock worth about $6.08M. Jonathan McNeill is the President and COO of CRESCENT BIOPHARMA, INC. and owns shares of GLYCOMIMETICS INC (GLYC) stock worth about $33.6K.
Signature
/s/ Barbara Bispham, as attorney-in-fact for Jonathan McNeill
All Insider Reports
All Insider Reports

Notify me when Jonathan McNeill files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Jonathan McNeill

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
DYN Dyne Therapeutics, Inc. Chief Business Officer $6.08M 19 Aug 2024
GLYC GLYCOMIMETICS INC President and COO $33.6K 08 Dec 2025

Insider Transactions Reported by Jonathan McNeill:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.